NCT01115504 Thiamine Supplementation in Heart Failure Patients Receiving Full Medical Therapy Status COMPLETED Phase PHASE3
NCT01104558 Association Between Genetic Polymorphism of Beta-adrenergic Receptor and Effects of Bisoprolol in Korean Heart Failure Patients. Status COMPLETED Phase PHASE4
NCT01092130 Study to Investigate the Effects of Vitamin D Administration on Plasma Renin Activity in Patients With Stable Chronic Heart Failure Status COMPLETED Phase PHASE2
NCT00984529 Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia Status COMPLETED Phase N/A
NCT00934609 Training Study to Evaluate the Benefit of Exercise for Patients With Chronic Heart Failure Status COMPLETED Phase NA
NCT00893685 Randomized Controlled Trial of Home Telemonitoring for Elderly People Status UNKNOWN Phase NA
NCT00887588 LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction Status COMPLETED Phase PHASE2
NCT00863421 Sleep Disordered Breathing in Patients With Chronic Heart Failure Status UNKNOWN Phase N/A
NCT00853658 Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure Status COMPLETED Phase PHASE3
NCT00852020 Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients Status COMPLETED Phase NA
NCT00821717 EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure Status TERMINATED Phase PHASE3
NCT00792402 Computerized Guideline in Heart Failure: Implementation Process and Impact Evaluation Status COMPLETED Phase N/A
NCT00751972 Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure Status COMPLETED Phase NA
NCT00739687 Safety & Efficacy of ALT-711 (Alagebrium) in Chronic Heart Failure Status TERMINATED Phase PHASE2
NCT00679484 Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24 Status TERMINATED Phase PHASE3